Sign in

CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853899721
Phone
305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
  1. UPLOAD Other SEC-generated Letter
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-4 Deal Registration Statement - Business Combination
  4. 425 Deal Prospectus/Communication re Business Combination
  5. 8-K Event Material agreement · Regulation FD disclosure
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 10-Q Report Quarterly Report
  8. UPLOAD Other SEC-generated Letter
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 425 Deal Prospectus/Communication re Business Combination
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. DRSLTR Other Correspondence Related to Draft Registration Statement
  19. 8-K Event Regulation FD disclosure · Other events
  20. 425 Deal Prospectus/Communication re Business Combination

Page 20 of 22 · 433 filings